Methotrexate is an antimetabolite used in cancer treatment, which, by inhibiting the enzyme dihydrofolate reductase, inhibits the synthesis of the purines and pyrimidines that are necessary for nucleic acid synthesis (25). The gene discussed is DHFR; the disease is cancer.